These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8558143)

  • 21. Comparison of three different methods for measurement of cervical cord atrophy in multiple sclerosis.
    Zivadinov R; Banas AC; Yella V; Abdelrahman N; Weinstock-Guttman B; Dwyer MG
    AJNR Am J Neuroradiol; 2008 Feb; 29(2):319-25. PubMed ID: 17974604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple sclerosis pathology: evolution of pathogenetic concepts.
    Lassmann H
    Brain Pathol; 2005 Jul; 15(3):217-22. PubMed ID: 16196388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors for multiple sclerosis: the importance of natural history studies.
    Ebers GC
    J Neurol; 2005 Sep; 252 Suppl 3():iii15-iii20. PubMed ID: 16170495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is inflammation important in early PPMS? a longitudinal MRI study.
    Ingle GT; Sastre-Garriga J; Miller DH; Thompson AJ
    J Neurol Neurosurg Psychiatry; 2005 Sep; 76(9):1255-8. PubMed ID: 16107362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imaging of multiple sclerosis: role in neurotherapeutics.
    Bakshi R; Minagar A; Jaisani Z; Wolinsky JS
    NeuroRx; 2005 Apr; 2(2):277-303. PubMed ID: 15897951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spinal cord atrophy and disability in multiple sclerosis over four years: application of a reproducible automated technique in monitoring disease progression in a cohort of the interferon beta-1a (Rebif) treatment trial.
    Lin X; Tench CR; Turner B; Blumhardt LD; Constantinescu CS
    J Neurol Neurosurg Psychiatry; 2003 Aug; 74(8):1090-4. PubMed ID: 12876240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of beta2 adrenoreceptors on peripheral blood mononuclear cells in patients with primary and secondary progressive multiple sclerosis: a longitudinal six month study.
    Zoukos Y; Thomaides TN; Kidd D; Cuzner ML; Thompson A
    J Neurol Neurosurg Psychiatry; 2003 Feb; 74(2):197-202. PubMed ID: 12531948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of chemokines in the CSF and correlation with clinical disease activity in patients with multiple sclerosis.
    Mahad DJ; Howell SJ; Woodroofe MN
    J Neurol Neurosurg Psychiatry; 2002 Apr; 72(4):498-502. PubMed ID: 11909910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Schwann cells are removed from the spinal cord after effecting recovery from paraplegia.
    Jasmin L; Janni G; Moallem TM; Lappi DA; Ohara PT
    J Neurosci; 2000 Dec; 20(24):9215-23. PubMed ID: 11124999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurological rehabilitation: from mechanisms to management.
    Thompson AJ
    J Neurol Neurosurg Psychiatry; 2000 Dec; 69(6):718-22. PubMed ID: 11080221
    [No Abstract]   [Full Text] [Related]  

  • 31. One year follow up study of primary and transitional progressive multiple sclerosis.
    Stevenson VL; Miller DH; Leary SM; Rovaris M; Barkhof F; Brochet B; Dousset V; Filippi M; Hintzen R; Montalban X; Polman CH; Rovira A; de Sa J; Thompson AJ
    J Neurol Neurosurg Psychiatry; 2000 Jun; 68(6):713-8. PubMed ID: 10811693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Axonal loss results in spinal cord atrophy, electrophysiological abnormalities and neurological deficits following demyelination in a chronic inflammatory model of multiple sclerosis.
    McGavern DB; Murray PD; Rivera-Quiñones C; Schmelzer JD; Low PA; Rodriguez M
    Brain; 2000 Mar; 123 Pt 3(Pt 3):519-31. PubMed ID: 10686175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuclear magnetic resonance monitoring of treatment and prediction of outcome in multiple sclerosis.
    Miller DH; Thompson AJ
    Philos Trans R Soc Lond B Biol Sci; 1999 Oct; 354(1390):1687-95. PubMed ID: 10603620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of tissue damage in multiple sclerosis by nuclear magnetic resonance.
    Barkhof F; van Walderveen M
    Philos Trans R Soc Lond B Biol Sci; 1999 Oct; 354(1390):1675-86. PubMed ID: 10603619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of three MR sequences for the detection of cervical cord lesions in patients with multiple sclerosis.
    Rocca MA; Mastronardo G; Horsfield MA; Pereira C; Iannucci G; Colombo B; Moiola L; Comi G; Filippi M
    AJNR Am J Neuroradiol; 1999 Oct; 20(9):1710-6. PubMed ID: 10543646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitation of spinal cord demyelination, remyelination, atrophy, and axonal loss in a model of progressive neurologic injury.
    McGavern DB; Murray PD; Rodriguez M
    J Neurosci Res; 1999 Nov; 58(4):492-504. PubMed ID: 10533042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis.
    Liu C; Edwards S; Gong Q; Roberts N; Blumhardt LD
    J Neurol Neurosurg Psychiatry; 1999 Mar; 66(3):323-30. PubMed ID: 10084530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploratory treatment trials in multiple sclerosis using MRI: sample size calculations for relapsing-remitting and secondary progressive subgroups using placebo controlled parallel groups.
    Tubridy N; Ader HJ; Barkhof F; Thompson AJ; Miller DH
    J Neurol Neurosurg Psychiatry; 1998 Jan; 64(1):50-5. PubMed ID: 9436727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. More immunotherapy for multiple sclerosis.
    Hughes RA; Sharrack B
    J Neurol Neurosurg Psychiatry; 1996 Sep; 61(3):239-41. PubMed ID: 8795592
    [No Abstract]   [Full Text] [Related]  

  • 40. MRI dynamics of brain and spinal cord in progressive multiple sclerosis.
    Kidd D; Thorpe JW; Kendall BE; Barker GJ; Miller DH; McDonald WI; Thompson AJ
    J Neurol Neurosurg Psychiatry; 1996 Jan; 60(1):15-9. PubMed ID: 8558143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.